Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-09

Clinical Trial Update: Nimodipine Variability in SAH

View source ↗

Summary

A University of Alberta-led clinical trial is evaluating variability in Nimodipine for subarachnoid hemorrhage and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimodipine (Nimodipine)

Snippet

Sponsor: University of Alberta | Conditions: Subarachnoid Aneurysm Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal | Status: RECRUITING